Recce Pharmaceuticals Ltd (RCE) is involved drug discovery and development business commercialising a new class of synthetic antibiotics with broad spectrum activity designed to address the global health challenge of antibiotic resistant superbugs. Its patented lead candidate known as RECCE 327 has been developed for the treatment of blood infections and sepsis. The Group operates in only one business segment being research and development and Group operates in two geographic segments being Australia and USA.
Recce Pharmaceuticals Ltd operators in Health Care sector and under industry of Pharmaceuticals. The company website is: http://www.recce.com.au.
You can also check out dividend history for similar stocks in the same sector as follows:
RCE Dividend Dates
Please click the table header to sort the data.
No Dividend Dates Found